Skip to main content
. 2012 Mar;97(3):442–450. doi: 10.3324/haematol.2011.043372

Figure 3.

Figure 3

(A) Progression-free survival in patients who achieved a CR following HDT with ASCT compared with those who achieved less than CR. (B) Overall survival according to induction therapy in patients who achieved a response (including no change) following HDT with ASCT (intent-to-treat analysis). ASCT: autologous stem-cell transplantation; CR: complete response; HDT: high-dose therapy.